News & Events

News

Medical Industry Leadership Institute image

Combating Minnesota's Opioid Epidemic

September 13, 2019

The University of Minnesota Carlson School of Management Medical Industry Leadership Institute is hosting "Combating Minnesota's Opioid Epidemic" on Thursday, October 24, 2019 from 8:30 a.m. to 4:30 p.m. at the Carlson School of Management. This event is a one-day policy forum convening public and private stakeholders in Minnesota and at the federal level to discuss how to collaboratively build upon current federal, state, and local efforts to combat the opioid epidemic. 
Learn more and register today. 

Center for Bioethics logo

Upcoming Events at the Center for Bioethics

August 20, 2019

The Center for Bioethics is kicking off fall semester with Ethics Ground Rounds and Mini Bioethics Academy. The Center for Bioethics' Ethics Grand Rounds is a series of monthly seminars featuring noted local, national, & international bioethics scholars lecturing on a variety of ethical issues in health care & the life sciences. The Mini Bioethics Academy is a three-evening series that engages with faculty and fosters discussion on complex, thought-provoking bioethical issues facing society. Read More.

Health Law Professors Logo

Profs. Wolf and Clayton Moderate Panel at 2019 Health Law Professors Conference in Chicago: LawSeq: Building a Legal Foundation for Genomics & Precision Medicine

July 8, 2019

Professor Susan M. Wolf, JD (University of Minnesota) and Professor Ellen Wright Clayton, JD, MD (Vanderbilt University), recently moderated a panel discussion on “LawSeq: Building a Legal Foundation for Genomics & Precision Medicine” at the 2019 Health Law Professors Conference, sponsored by the American Society of Law, Medicine & Ethics and Loyola University Chicago School of Law. Panelists included Professor Barbara J. Evans, LLM, JD, PhD (University of Houston), Professor Gary Marchant, JD, MPP, PhD (Arizona State University), and Professor Mark Rothstein, JD (University of Louisville). Based cooperatively at the University of Minnesota and Vanderbilt University Medical Center, the LawSeqSM project has convened a national working group of top legal and scientific experts to compile, collect, and analyze current US federal and state law and regulation on translational genomics. Read More

Prof. Leigh Turner

Turner Warns of Explosive Growth in Bogus Stem Cell Therapies

June 18, 2019

According to Wired magazine, "Since the mid-2000s, clinics have been selling expensive, unproven stem-cell treatments to any patient desperate enough to believe their claims of cures for everything from arthritis to autism." These clinics have "been tied to serious infections, several cases of blindness, and one patient’s death." Leigh Turner, a professor at the Center for Bioethics, a Consortium member, has authored several major research papers on the growing availability of questionable stem-cell therapies. Turner notes that despite greater FDA scutiny, which includes an "increase the rule changes and the public hearings and more inspections and warning letters and the lawsuits, the market is still expanding at a rapid rate.” A recent Pro Publica/New Yorker investigation provides additional details of the promotional methods and dubious science that ensnares consumers in these dangerous interventions.

Center for Spirituality and Healing logo

CSH Offers Wide Variety of Wellbeing Resources

June 11, 2019

The Earl E. Bakken Center for Spirituality and Healing (CSH), a Consortium member, is among the nation's leading institutions dedicated to research-based approaches to integrative health and healing. CSH is an interdisciplinary unit of the University's Academic Health Center, School of Nursing, Medical School, College of Veterinary Medicine, College of Pharmacy, School of Public Health, and School of Dentistry. Among the resources available from CSH is a website, Taking Charge of Your Health & Wellbeing, which provides a self-assessment tool, goal-setting advice, and information about trying holistic practices and managing health conditions. Check out the website here

Dome of US Capitol Building

Gene Patent Policy Under Review by Congress

June 6, 2019

A new article in Wired by Megan Molteni describes potentially momentous changes in the legal status of gene patents. According to Molteni, "In 2013, the Supreme Court unanimously struck down patents on two human genes – BRCA1 and BRCA2 – associated with breast and ovarian cancers. Justice Clarence Thomas wrote for the court at the time that isolated DNA 'is a product of nature and not patent eligible.' The historic decision invalidated patents held by Myriad Genetics" and opened the way for companies like 23andMe to offer direct-to-consumer tests of BRCA and other genes. A new bill making its way through Congress would make "changes to several sections of the statutes covering patent law and [add] a provision that would nullify the Supreme Court’s exceptions." The congressional debate is driven by concerns that overly stringent patent rules are hindering US companies from creating potentially lucrative new diagnostic tools, allowing rivals like China to outpace American innovation. Hearings are currently underway to clarify the intention of the bill and ensure it effectively addresses industry concerns. Read the entire Wired article here, and one on the same topic from GenomeWeb here. For more information about genomics law and policy, visit the NIH-funded LawSeqSM website, created by the Consortium in collaboration with Vanderbilt University. 

Pages

Upcoming Events